To address whether CaMKII mediates synaptic adaptations in our slices as it does in some known forms of HSP, we inhibited the holoenzyme using the CN21 peptide, a 21 amino-acid sequence derived from an endogenous protein, a specific and efficient CaMKII inhibitor. Here, CAMK2G is linked to hereditary spastic paraplegia.